|
1
|
Brun JL, Feyler A, Chêne G, Saurel J, Brun
G and Hocké C: Long-term results and prognostic factors in patients
with epithelial ovarian cancer. Gynecol Oncol. 78:21–27. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rakoff-Nahoum S and Medzhitov R: Toll-like
receptors and cancer. Nat Rev Cancer. 9:57–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim S, Takahashi H, Lin WW, Descargues P,
Grivennikov S, Kim Y, Luo JL and Karin M: Carcinoma-produced
factors activate myeloid cells through TLR2 to stimulate
metastasis. Nature. 457:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harmey JH, Bucana CD, Lu W, Byrne AM,
McDonnell S, Lynch C, Bouchier-Hayes D and Dong Z:
Lipopolysaccharide-induced metastatic growth is associated with
increased angiogenesis, vascular permeability and tumor cell
invasion. Int J Cancer. 101:415–422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa
T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW and Selander
KS: Toll-like receptor 9 agonists promote cellular invasion by
increasing matrix metalloproteinase activity. Mol Cancer Res.
4:437–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou M, McFarland-Mancini MM, Funk HM,
Husseinzadeh N, Mounajjed T and Drew AF: Toll-like receptor
expression in normal ovary and ovarian tumors. Cancer Immunol
Immunother. 58:1375–1385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang K and Pastan I: Molecular cloning of
mesothelin, a differentiation antigen present on mesothelium,
mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA. 93:pp.
136–140. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang MC, Chen CA, Chen PJ, Chiang YC,
Chen YL, Mao TL, Lin HW, Lin Chiang WH and Cheng WF: Mesothelin
enhances invasion of ovarian cancer by inducing MMP-7 through
MAPK/ERK and JNK pathways. Biochem J. 442:293–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Servais EL, Colovos C, Rodriguez L, Bograd
AJ, Nitadori J, Sima C, Rusch VW, Sadelain M and Adusumilli PS:
Mesothelin overexpression promotes mesothelioma cell invasion and
MMP-9 secretion in an orthotopic mouse model and in epithelioid
pleural mesothelioma patients. Clin Cancer Res. 18:2478–2489. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rump A, Morikawa Y, Tanaka M, Minami S,
Umesaki N, Takeuchi M and Miyajima A: Binding of ovarian cancer
antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol
Chem. 279:9190–9198. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Markman M, Federico M, Liu PY, Hannigan E
and Alberts D: Significance of early changes in the serum CA-125
antigen level on overall survival in advanced ovarian cancer.
Gynecol Oncol. 103:195–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen SH, Hung WC, Wang P, Paul C and
Konstantopoulos K: Mesothelin binding to CA125/MUC16 promotes
pancreatic cancer cell motility and invasion via MMP-7 activation.
Sci Rep. 3:18702013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bharadwaj U, Marin-Muller C, Li M, Chen C
and Yao Q: Mesothelin confers pancreatic cancer cell resistance to
TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and
IL-6/Mcl-1 overexpression. Mol Cancer. 10:1062011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu L and Chen S: Toll-like receptors
expressed in tumor cells: Targets for therapy. Cancer Immunol
Immunother. 57:1271–1278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park GB, Chung YH and Kim D: Induction of
galectin-1 by TLR-dependent PI3K activation enhances
epithelial-mesenchymal transition of metastatic ovarian cancer
cells. Oncol Rep. 37:3137–3145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suetsugu S and Takenawa T: Regulation of
cortical actin networks in cell migration. Int Rev Cytol.
229:245–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Suetsugu S, Yamazaki D, Kurisu S and
Takenawa T: Differential roles of WAVE1 and WAVE2 in dorsal and
peripheral ruffle formation for fibroblast cell migration. Dev
Cell. 5:595–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kulkarni S, Augoff K, Rivera L, McCue B,
Khoury T, Groman A, Zhang L, Tian L and Sossey-Alaoui K: Increased
expression levels of WAVE3 are associated with the progression and
metastasis of triple negative breast cancer. PLoS One.
7:e428952012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji Y, Li B, Zhu Z, Guo X, He W, Fan Z and
Zhang W: Over-expression of WAVE3 promotes tumor invasiveness and
confers an unfavorable prognosis in human hepatocellular carcinoma.
Biomed Pharmacother. 69:409–415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moazzam M, Ye L, Sun PH, Kynaston H and
Jiang WG: Knockdown of WAVE3 impairs HGF induced migration and
invasion of prostate cancer cells. Cancer Cell Int. 15:512015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sossey-Alaoui K, Li X, Ranalli TA and
Cowell JK: WAVE3-mediated cell migration and lamellipodia formation
are regulated downstream of phosphatidylinositol 3-kinase. J Biol
Chem. 280:21748–21755. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rutkowski MR, Stephen TL, Svoronos N,
Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E,
Escovar-Fadul X, Nguyen JM, Cadungog MG, et al: Microbially driven
TLR5-dependent signaling governs distal malignant progression
through tumor-promoting inflammation. Cancer Cell. 27:27–40. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park GB, Chung YH, Gong JH, Jin DH and Kim
D: GSK-3β-mediated fatty acid synthesis enhances epithelial to
mesenchymal transition of TLR4-activated colorectal cancer cells
through regulation of TAp63. Int J Oncol. 49:2163–2172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beaufort CM, Helmijr JC, Piskorz AM,
Hoogstraat M, Ruigrok-Ritstier K, Besselink N, Murtaza M, van IJcken
WF, Heine AA, Smid M, et al: Ovarian cancer cell line panel (OCCP):
Clinical importance of in vitro morphological subtypes. PLoS One.
9:e1039882014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leis O, Eguiara A, Lopez-Arribillaga E,
Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R
and Martin AG: Sox2 expression in breast tumours and activation in
breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ,
Gimotty PA, Guerra M, Guo W and Xu X: Acquired cancer stem cell
phenotypes through Oct4-mediated dedifferentiation. Oncogene.
31:4898–4911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kelly MG, Alvero AB, Chen R, Silasi DA,
Abrahams VM, Chan S, Visintin I, Rutherford T and Mor G: TLR-4
signaling promotes tumor growth and paclitaxel chemoresistance in
ovarian cancer. Cancer Res. 66:3859–3868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng WF, Huang CY, Chang MC, Hu YH,
Chiang YC, Chen YL, Hsieh CY and Chen CA: High mesothelin
correlates with chemoresistance and poor survival in epithelial
ovarian carcinoma. Br J Cancer. 100:1144–1153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bast RC Jr: Status of tumor markers in
ovarian cancer screening. J Clin Oncol. 21 Suppl 10:200–205. 2003.
View Article : Google Scholar
|
|
33
|
Shimizu A, Hirono S, Tani M, Kawai M,
Okada K, Miyazawa M, Kitahata Y, Nakamura Y, Noda T, Yokoyama S, et
al: Coexpression of MUC16 and mesothelin is related to the invasion
process in pancreatic ductal adenocarcinoma. Cancer Sci.
103:739–746. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Millard TH, Sharp SJ and Machesky LM:
Signalling to actin assembly via the WASP (Wiskott-Aldrich syndrome
protein)-family proteins and the Arp2/3 complex. Biochem J.
380:1–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miki H, Suetsugu S and Takenawa T: WAVE, a
novel WASP-family protein involved in actin reorganization induced
by Rac. EMBO J. 17:6932–6941. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sossey-Alaoui K, Ranalli TA, Li X, Bakin
AV and Cowell JK: WAVE3 promotes cell motility and invasion through
the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res.
308:135–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Davuluri G, Augoff K, Schiemann WP, Plow
EF and Sossey-Alaoui K: WAVE3-NFκB interplay is essential for the
survival and invasion of cancer cells. PLoS One. 9:e1106272014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang A, Kaghad M, Wang Y, Gillett E,
Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F: p63, a p53
homolog at 3q27-29, encodes multiple products with transactivating,
death-inducing, and dominant-negative activities. Mol Cell.
2:305–316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koga F, Kawakami S, Fujii Y, Saito K,
Ohtsuka Y, Iwai A, Ando N, Takizawa T, Kageyama Y and Kihara K:
Impaired p63 expression associates with poor prognosis and
uroplakin III expression in invasive urothelial carcinoma of the
bladder. Clin Cancer Res. 9:5501–5507. 2003.PubMed/NCBI
|
|
41
|
Barbieri CE, Tang LJ, Brown KA and
Pietenpol JA: Loss of p63 leads to increased cell migration and
up-regulation of genes involved in invasion and metastasis. Cancer
Res. 66:7589–7597. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luo W, Li S, Peng B, Ye Y, Deng X and Yao
K: Embryonic stem cells markers SOX2, OCT4 and Nanog expression and
their correlations with epithelial-mesenchymal transition in
nasopharyngeal carcinoma. PLoS One. 8:e563242013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li X, Xu Y, Chen Y, Chen S, Jia X, Sun T,
Liu Y, Li X, Xiang R and Li N: SOX2 promotes tumor metastasis by
stimulating epithelial-to-mesenchymal transition via regulation of
WNT/β-catenin signal network. Cancer Lett. 336:379–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Alexandrova EM, Petrenko O, Nemajerova A,
Romano RA, Sinha S and Moll UM: ∆Np63 regulates select routes of
reprogramming via multiple mechanisms. Cell Death Differ.
20:1698–1708. 2013. View Article : Google Scholar : PubMed/NCBI
|
